|Bid||0.0000 x 4000|
|Ask||0.0000 x 900|
|Day's Range||4.5000 - 4.7103|
|52 Week Range||2.6000 - 13.0000|
|Beta (5Y Monthly)||0.83|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2021 - May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.00|
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it will release financial results for the three months ended March 31, 2021 after the market closes on Wednesday, May 12, 2021. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).
Biocept to provide COVID-19 testing to California community colleges and their more than 2.1 million students through FCCC partnership.
Biocept announces full launch of CNSide, its CSF assay designed to improve the management of metastatic cancers involving the central nervous system.